Primary Site >> Colorectal Cancer

Gene >> IFNA1

Journal: Cancer Res. 1983 Jun;43(6):2683-7.
Title: Effects of fibroblast and recombinant leukocyte interferons and double-stranded RNA on ppp(2'-5')An synthesis and cell proliferation in human colon carcinoma cells in vitro.
Author: Chapekar, M S|Glazer, R I
PMID: 6189584
Journal: Int J Cancer. 1984 Feb 15;33(2):251-6.
Title: Treatment of patients with disseminated colorectal cancer with recombinant human alpha 2-interferon. Studies on the immune system.
Author: Einhorn, S|Wasserman, J|Lundell, G|Blomgren, H|Cedermark, B|Jarstrand, C|Petrini, B|Strander, H|Theve, T|Ohman, U
PMID: 6229496
Journal: Cancer Res. 1984 Aug;44(8):3208-14.
Title: Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment.
Author: Greiner, J W|Hand, P H|Noguchi, P|Fisher, P B|Pestka, S|Schlom, J
PMID: 6744259
Journal: Eur J Immunol. 1985 Feb;15(2):118-23.
Title: Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
Author: Carrel, S|Schmidt-Kessen, A|Giuffre, L
PMID: 3918869
Journal: J Natl Cancer Inst. 1985 Jun;74(6):1261-8.
Title: HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Author: Shaw, A R|Chan, J K|Reid, S|Seehafer, J
PMID: 3923246
Journal: Oncology. 1985;42(3):157-63.
Title: Leukocyte adherence inhibition, natural killer cell activity, gamma-interferon production capacity and phytohemagglutinin response in patients treated with recombinant leukocyte A interferon.
Author: Tank, B|Bijma, A M|Marquet, R L|Eggermont, A M|Weimar, W|Jeekel, J|Westbroek, D L
PMID: 3923413
Journal: Eur J Cancer Clin Oncol. 1986 Jun;22(6):685-9.
Title: Difluoromethylornithine and leukocyte interferon: a phase I study in cancer patients.
Author: Talpaz, M|Plager, C|Quesada, J|Benjamin, R|Kantarjian, H|Gutterman, J
PMID: 3091371
Journal: Nihon Geka Gakkai Zasshi. 1986 Aug;87(8):834-45.
Title: [Experimental and clinical studies on chemosensitivity tests of anticancer agents by human tumor clonogenic assay].
Author: Hirabayashi, N
PMID: 3092023
Journal: Gan To Kagaku Ryoho. 1987 May;14(5 Pt 1):1234-9.
Title: [Combined effect of human recombinant interferon alpha, beta and gamma on tumor cell growth and the cell cycle in vitro].
Author: Kondo, H|Tanaka, N|Naomoto, Y|Orita, K
PMID: 3107476
Journal: Int J Colorectal Dis. 1987 Feb;2(1):26-9.
Title: Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (trial 1) and in combination with 5-fluorouracil (trial 2) in advanced colorectal cancer.
Author: Clark, P I|Slevin, M L|Reznek, R H|Niederle, N|Kurschel, E|Lundell, G|Cedermark, B|Fallenius, A|Blomgren, H|Ohman, U
PMID: 3598328
Journal: Cancer Res. 1987 Apr 15;47(8):2020-7.
Title: Direct antiproliferative effects of recombinant human interferon-alpha B/D hybrids on human tumor cell lines.
Author: Fidler, I J|Heicappell, R|Saiki, I|Grutter, M G|Horisberger, M A|Nuesch, J
PMID: 3828990
Journal: Anticancer Res. 1988 Jan-Feb;8(1):197-203.
Title: Effects of interferons alpha,beta,gamma alone or in combination on the phenotype of human colon carcinoma cells.
Author: Brouty-Boye, D|Maunoury, M T|Lowy, R
PMID: 2451894
Journal: Biochem Biophys Res Commun. 1988 Jun 30;153(3):1276-81.
Title: Interferon-gamma activates the voltage-gated calcium channel in RPMI 4788 cells.
Author: Iwagaki, H|Fuchimoto, S|Miyake, M|Aoki, H|Orita, K
PMID: 2455515
Journal: Gan To Kagaku Ryoho. 1988 Aug;15(8):2285-90.
Title: [Combined effects of interferon alpha-A/D with fluoropyrimidine derivatives in the subrenal capsule assay].
Author: Nishiyama, M|Takagami, S|Kirihara, Y|Saeki, T|Niimi, K|Kim, R|Jinushi, K|Toge, T|Niimoto, M|Hattori, T
PMID: 3136700
Journal: Jpn J Cancer Res. 1988 Sep;79(9):1054-61.
Title: Hyperthermic enhancement of the antitumor effect of natural human tumor necrosis factor-alpha and -beta: an in vitro and in vivo study.
Author: Maeda, T|Fuchimoto, S|Orita, K
PMID: 3142836
Journal: Br J Cancer. 1988 Aug;58(2):147-51.
Title: Inhibition of mitogen stimulated growth of human colon cancer cells by interferon.
Author: Hamburger, A W|Condon, M E|O'Donnell, K
PMID: 3166905
Journal: Cancer Res. 1989 Jan 15;49(2):265-70.
Title: Membrane-associated interleukin 1 alpha as a mediator of tumor cell killing by human blood monocytes fixed with paraformaldehyde.
Author: Okubo, A|Sone, S|Tanaka, M|Ogura, T
PMID: 2463072
Journal: J Biol Response Mod. 1989 Apr;8(2):206-18.
Title: Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.
Author: Morikawa, K|Fidler, I J
PMID: 2499665
Journal: Int J Cancer. 1989 Jan 15;43(1):140-6.
Title: Action of recombinant alpha interferon against experimental and spontaneous metastases in a murine model.
Author: Ramani, P|Balkwill, F R
PMID: 2910826
Journal: Cancer Res. 1990 Jun 15;50(12):3473-86.
Title: Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.
Author: Wadler, S|Schwartz, E L
PMID: 1692761
Journal: Cancer Res. 1990 Sep 15;50(18):5735-9.
Title: Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects.
Author: Wadler, S|Wersto, R|Weinberg, V|Thompson, D|Schwartz, E L
PMID: 1697499
Journal: Anticancer Res. 1990 Nov-Dec;10(6):1491-500.
Title: Isolation and characterization of a human monoclonal antibody which reacts with breast and colorectal carcinoma.
Author: Goldstein, N I|Nagle, R|Villar, H|Hersh, E|Fisher, P B
PMID: 1704693
Journal: J Interferon Res. 1990 Dec;10(6):579-88.
Title: The effect of interferon treatment on 14 human colorectal cancer cell lines: growth and carcinoembryonic antigen secretion in vitro.
Author: Toth, C A|Thomas, P
PMID: 1707938
Journal: Onkologie. 1990 Dec;13(6):416-22.
Title: The clinical significance of interleukin-2.
Author: Bergmann, L
PMID: 2092277
Journal: Adv Exp Med Biol. 1990;276:497-503.
Title: Comparison of the replication of distinct strains of human coronavirus OC43 in organotypic human colon cells (Caco-2) and mouse intestine.
Author: Collins, A R
PMID: 2103102
Journal: J Natl Cancer Inst. 1990 Mar 21;82(6):517-22.
Title: Isolation of human colon carcinoma cells for resistance to a single interferon associated with cross-resistance to multiple recombinant interferons: alpha, beta, and gamma.
Author: Morikawa, K|Morikawa, R|Killion, J J|Fan, D|Fidler, I J
PMID: 2138228
Journal: J Immunol. 1990 May 1;144(9):3643-8.
Title: IFN-alpha and IFN-gamma can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity.
Author: Webb, D S|Gerrard, T L
PMID: 2158515
Journal: Cancer. 1990 Aug 15;66(4):664-9.
Title: A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma.
Author: Mittelman, A|Huberman, M|Puccio, C|Fallon, B|Tessitore, J|Savona, S|Eyre, R|Gafney, E|Wick, M|Skelos, A
PMID: 2386896
Journal: J Immunol. 1991 May 15;146(10):3682-6.
Title: Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis.
Author: Webb, D S|Mostowski, H S|Gerrard, T L
PMID: 1673988
Journal: Semin Oncol. 1991 Oct;18(5 Suppl 7):77-82.
Title: Mechanisms of interaction of interferon and 5-fluorouracil in solid tumors.
Author: Neefe, J R|John, W
PMID: 1719644
Journal: Jpn J Cancer Res. 1991 Jan;82(1):118-26.
Title: Mechanism of the combined antitumor effect of natural human tumor necrosis factor-alpha and natural human interferon-alpha on cell cycle progression.
Author: Muro, M|Naomoto, Y|Orita, K
PMID: 1825650
Journal: Cancer Res. 1991 Sep 15;51(18):4898-902.
Title: Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells.
Author: Scala, S|Pacelli, R|Iaffaioli, R V|Normanno, N|Pepe, S|Frasci, G|Genua, G|Tsuruo, T|Tagliaferri, P|Bianco, A R
PMID: 1893380
Journal: Br J Haematol. 1991 Oct;79 Suppl 1:52-5.
Title: Rational basis for the metabolic modulation of 5-fluorouracil by leucovorin and interferon alpha.
Author: Rustum, Y M
PMID: 1931710
Journal: Cancer Chemother Pharmacol. 1991;28(6):420-6.
Title: Chemosensitivity and cytokine sensitivity of malignant mesothelioma.
Author: Bowman, R V|Manning, L S|Davis, M R|Robinson, B W
PMID: 1934246
Journal: Eur J Cancer. 1992;28A(11):1820-3.
Title: Phase II trial of 5-fluorouracil and recombinant interferon alfa-2B in metastatic colorectal carcinoma.
Author: Weh, H J|Platz, D|Braumann, D|Buggisch, P|Eckardt, N|Schmiegel, W H|Drescher, S|Kleeberg, U R|Mullerleile, U|Crone-Munzebrock, W
PMID: 1389518
Journal: Cancer. 1992 Oct 15;70(8):2087-90.
Title: Evidence for an association between hairy cell leukemia and renal cell and colorectal carcinoma.
Author: Nielsen, B|Braide, I|Hasselbalch, H
PMID: 1394039
Journal: Ann Oncol. 1992 Jun;3(6):489-91.
Title: Double biochemical modulation of 5-fluorouracil by leucovorin and cyclic low dose interferon alpha 2b in advanced colorectal cancer patients.
Author: Cascinu, S|Fedeli, A|Fedeli, S L|Catalano, G
PMID: 1498068
Journal: Eur J Cancer. 1992;28A(4-5):850-2.
Title: Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancer.
Author: Sobrero, A|Nobile, M T|Guglielmi, A|Mori, A|Aschele, C|Bolli, E|Tixi, L|Gallo, L|Parodi, G C|Bruzzi, P
PMID: 1524906
Journal: Biochem Biophys Res Commun. 1992 Feb 14;182(3):1232-9.
Title: Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells.
Author: Schwartz, E L|Hoffman, M|O'Connor, C J|Wadler, S
PMID: 1540167
Journal: Semin Oncol. 1992 Apr;19(2 Suppl 4):57-62.
Title: A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
Author: Kreuser, E D|Hilgenfeld, R U|Matthias, M|Hoksch, B|Boewer, C|Oldenkott, B|Lenk, H|Wiener, N|Boese-Landgraf, J|Schalhorn, A
PMID: 1553576
Journal: Semin Oncol. 1992 Apr;19(2 Suppl 3):171-5.
Title: Alfa-2A interferon and 5-fluorouracil for advanced colorectal carcinoma: the Memorial Sloan-Kettering experience.
Author: Kemeny, N|Younes, A
PMID: 1557642
Journal: Semin Oncol. 1992 Apr;19(2 Suppl 3):197-203.
Title: A phase I trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
Author: Kreuser, E D|Hilgenfeld, R U|Matthias, M|Hoksch, B|Boewer, C|Oldenkott, B|Knauf, W U|Boese-Landgraf, J|Schalhorn, A|Zeitz, M
PMID: 1557647
Journal: Semin Oncol. 1992 Apr;19(2 Suppl 3):204-7.
Title: Treatment of refractory colorectal carcinomas with fluorouracil, folinic acid, and interferon alfa-2a.
Author: Bernhard, H|Klein, O|Meyer zum Buschenfelde, K H|Knuth, A
PMID: 1557648
Journal: Semin Oncol. 1992 Apr;19(2 Suppl 3):208-10.
Title: Fluorouracil continuous infusion plus alfa interferon plus oral folinic acid in advanced colorectal cancer.
Author: Punt, C J|de Mulder, P H|Burghouts, J T|Wagener, D J
PMID: 1557649
Journal: Semin Oncol. 1992 Apr;19(2 Suppl 3):211-4.
Title: Combination fluorouracil, folinic acid, and interferon alfa-2a: an active regimen in advanced pancreatic carcinoma.
Author: Knuth, A|Bernhard, H|Klein, O|Meyer zum Buschenfelde, K H
PMID: 1557650
Journal: Semin Oncol. 1992 Apr;19(2 Suppl 3):215-9.
Title: Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal, and pancreatic cancer.
Author: Wilke, H|Stahl, M|Schmoll, H J|Preusser, P|Fink, U|Meyer, H J|Achterrath, W|Knipp, H|Kohne-Wompner, C H|Harstrick, A
PMID: 1557651
Journal: J Immunother (1991). 1992 Feb;11(2):77-84.
Title: Effects of recombinant human gamma-interferon on carcinoembryonic antigen expression of human colon cancer cells.
Author: Yan, X W|Wong, J Y|Esteban, J M|Kuhn, J A|Beatty, B G|Beatty, J D|Shively, J E
PMID: 1571334
Journal: Tumori. 1992 Feb 29;78(1):32-4.
Title: High dose alpha-2b interferon + folinic acid in the modulation of 5-fluorouracil. A phase II study in advanced colorectal cancer with evidence of an unfavourable cost/benefit ratio.
Author: Labianca, R|Pancera, G|Tedeschi, L|Dallavalle, G|Luporini, A|Luporini, G
PMID: 1609456
Journal: J Chemother. 1993 Aug;5(4):271-7.
Title: The role of interferons in the treatment of colorectal cancer.
Author: Fountzilas, G|Zissiadis, A
PMID: 7693882
Journal: Immunol Lett. 1993 Nov;38(3):215-22.
Title: TNF alpha protects SW742 human colon carcinoma cells against non-MHC-restricted cytolysis.
Author: Bacon, C M|Lawry, J|Rees, R C
PMID: 7907319
Journal: Cancer Immunol Immunother. 1993 Jul;37(2):112-8.
Title: Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules.
Author: Darley, R|Morris, A|Passas, J|Bateman, W
PMID: 8100485
Journal: Cancer Res. 1993 Nov 15;53(22):5429-32.
Title: Cytokinetic effects of interferon in colorectal cancer tumors: implications in the design of the interferon/5-fluorouracil combinations.
Author: Cascinu, S|Del Ferro, E|Fedeli, A|Grianti, C|Foglietti, G|Olivieri, Q|Acetoso, M|Bartolucci, M|Saba, V|Lungarotti, F
PMID: 8221681
Journal: Gan To Kagaku Ryoho. 1993 Nov;20(14):2239-42.
Title: [A case of pulmonary metastasis from colon cancer successfully treated by 5-FU combined with leucovorin and interferon alpha-2a].
Author: Ichiki, Y|Nakano, S|Hirata, Y|Nakamura, M|Kanaya, S|Niho, Y
PMID: 8239693
Journal: Anticancer Drugs. 1993 Oct;4(5):555-7.
Title: A phase II study of 5-fluorouracil, leucovorin and interferon-alpha in advanced pancreatic cancer.
Author: Moore, M J|Erlichman, C|Kaizer, L|Fine, S
PMID: 8292812
Journal: Clin Exp Immunol. 1993 Oct;94(1):4-10.
Title: Peri-operative modulation of cellular immunity in patients with colorectal cancer.
Author: Nichols, P H|Ramsden, C W|Ward, U|Trejdosiewicz, L K|Ambrose, N S|Primrose, J N
PMID: 8403515
Journal: J Clin Oncol. 1993 Jan;11(1):148-51.
Title: Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial.
Author: Cascinu, S|Fedeli, A|Fedeli, S L|Catalano, G
PMID: 8418225
Journal: Cancer. 1993 Mar 1;71(5):1726-30.
Title: Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferon.
Author: Wadler, S|Fell, S|Haynes, H|Katz, H J|Rozenblit, A|Kaleya, R|Wiernik, P H
PMID: 8448736
Journal: Gan To Kagaku Ryoho. 1993 Mar;20(4):493-8.
Title: [Treatment of advanced gastric and colorectal cancer with 5-FU, leucovorin and interferon-alpha].
Author: Tsujimura, T|Ezaki, K|Ono, Y|Nakano, H|Kawase, K|Iwase, K|Hatanaka, T|Ohara, K|Hobara, R|Okamoto, M
PMID: 8452387
Journal: Cancer. 1993 Apr 1;71(7):2358-70.
Title: Inpatient continuous-infusion interleukin-2 in 788 patients with cancer. The National Biotherapy Study Group experience.
Author: Dillman, R O|Church, C|Oldham, R K|West, W H|Schwartzberg, L|Birch, R
PMID: 8453558
Journal: Cancer Invest. 1993;11(3):310-3.
Title: Mechanisms by which interferon potentiates chemotherapy.
Author: Hoffman, M A|Wadler, S
PMID: 8485653
Journal: Int J Clin Pharmacol Res. 1993;13(1):1-9.
Title: Clinical and pharmacological studies of interferon and chemotherapy in gastrointestinal and breast cancer.
Author: Sparano, J A|Wadler, S|Schwartz, E L|Diasio, R
PMID: 8509231
Journal: Eur J Cancer. 1994;30A(11):1611-6.
Title: Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-alpha 2b and folinic acid. The "GISCAD" experience. Italian Group for the Study of Digestive Tract Cancer.
Author: Labianca, R|Giaccon, G|Barni, S|Ambrosini, G|Iirillo, A|Fiorentini, G|Duro, M|Piazza, E|Oliani, C|Pancera, G
PMID: 7833131
Journal: Anticancer Res. 1994 Sep-Oct;14(5A):1767-73.
Title: Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cells.
Author: De Filippi, R|Prete, S P|Giuliani, A|Silvi, E|Yamaue, H|Nieroda, C A|Greiner, J W|De Vecchis, L|Bonmassar, E
PMID: 7847809
Journal: Br J Cancer. 1994 Nov;70(5):946-9.
Title: The effect of 5-fluorouracil and alpha interferon and 5-fluorouracil and leucovorin on cellular anti-tumour immune responses in patients with advanced colorectal cancer.
Author: Nichols, P H|Ward, U|Ramsden, C W|Primrose, J N
PMID: 7947102
Journal: Ann Oncol. 1994 Mar;5(3):233-7.
Title: Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma. A multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO).
Author: Weh, H J|Wilke, H J|Dierlamm, J|Klaassen, U|Siegmund, R|Illiger, H J|Schalhorn, A|Kreuser, E D|Hilgenfeld, U|Steinke, B
PMID: 8186170
Journal: Int J Oncol. 1994 Aug;5(2):181-8.
Title: Induction by human interferon and murine h-2l(d) gene of the surface expression of endogenous hla class-I free heavy-chains in hct human colon-carcinoma cells, deficient in Beta-2-microglobulin.
Author: Simile, M|Calorini, L|Ryan, M|Gattonicelli, S
PMID: 21559573
Journal: Cancer Immunol Immunother. 1995 May;40(5):311-4.
Title: Interferon alpha enhances expression of TAG-72 and carcinoembryonic antigen in patients with primary colorectal cancer.
Author: Mahvi, D M|Madsen, J A|Witt, P L|Sondel, P M
PMID: 7600563
Journal: Gan To Kagaku Ryoho. 1995 Jul;22(8):1018-27.
Title: [Biomodulation of 5-fluorouracil by interferon].
Author: Aiba, K
PMID: 7611752
Journal: Cancer Res. 1995 Aug 15;55(16):3543-50.
Title: 5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression.
Author: Schwartz, E L|Baptiste, N|Megati, S|Wadler, S|Otter, B A
PMID: 7627962
Journal: J Biol Chem. 1995 Aug 11;270(32):19073-7.
Title: Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil.
Author: Schwartz, E L|Baptiste, N|Wadler, S|Makower, D
PMID: 7642571
Journal: Eur J Cancer. 1995 Jun;31A(6):1002-8.
Title: Treatment of advanced colorectal cancer with 5-fluorouracil and interferon-alpha: an overview of clinical trials.
Author: Raderer, M|Scheithauer, W
PMID: 7646900
Journal: Cancer Lett. 1995 Aug 16;95(1-2):57-62.
Title: The correlation of thymidine phosphorylase activity with the expression of interleukin 1 alpha, interferon alpha and interferon gamma in human colorectal carcinoma.
Author: Takebayashi, Y|Yamada, K|Ohmoto, Y|Sameshima, T|Miyadera, K|Yamada, Y|Akiyama, S|Aikou, T
PMID: 7656244
Journal: J Clin Oncol. 1995 Sep;13(9):2317-23.
Title: Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer.
Author: Hill, M|Norman, A|Cunningham, D|Findlay, M|Watson, M|Nicolson, V|Webb, A|Middleton, G|Ahmed, F|Hickish, T
PMID: 7666089
Journal: Cancer. 1995 May 15;75(10):2592-6.
Title: Reversible hepatic steatosis in patients treated with interferon alfa-2a and 5-fluorouracil.
Author: Sorensen, P|Edal, A L|Madsen, E L|Fenger, C|Poulsen, M R|Petersen, O F
PMID: 7736406
Journal: Cancer Biother. 1995 Spring;10(1):5-12.
Title: Subcutaneous interleukin-2 and alpha-interferon in advanced colorectal carcinoma. A phase II study.
Author: Hjelm, A L|Ragnhammar, P|Fagerberg, J|Magnusson, I|Frodin, J E|Svanstrom, R|Shetye, J|Mellstedt, H|Wersall, J P
PMID: 7780487
Journal: Eur J Cancer. 1995;31A(3):315-20.
Title: Different dose regimens of 5-fluorouracil and interferon-alpha in patients with metastatic colorectal carcinoma.
Author: Ragnhammar, P|Blomgren, H|Edler, D|Lundell, G|Magnusson, I|Sonnenfeld, T
PMID: 7786594
Journal: Immunol Cell Biol. 1995 Apr;73(2):140-5.
Title: Productive in vitro infection of human umbilical vein endothelial cells and three colon carcinoma cell lines with HIV-1.
Author: Corbeil, J|Evans, L A|McQueen, P W|Vasak, E|Edward, P D|Richman, D D|Penny, R|Cooper, D A
PMID: 7797233
Journal: Med Oncol. 1995 Mar;12(1):47-53.
Title: Pharmacokinetic interaction of 5-fluorouracil and interferon alpha-2b with or without folinic acid.
Author: b1p6uller, J|Czejka, M
PMID: 8542247
Journal: Anticancer Res. 1995 Sep-Oct;15(5B):1949-52.
Title: Anti-proliferative and cytokinetic effects of tumor necrosis factor-alpha, interferon-alpha and 5-fluorouracil on a human tumor xenograft.
Author: Tanaka, N|Kojima, K|Muro, M|Naomoto, Y|Moreira, L F|Orita, K
PMID: 8572582
Journal: J Immunother Emphasis Tumor Immunol. 1995 Nov;18(4):253-62.
Title: A phase II trial of interleukin-2 and interferon-alpha in the treatment of metastatic colorectal carcinoma.
Author: Chang, A E|Cameron, M J|Sondak, V K|Geiger, J D|Vander Woude, D L
PMID: 8680653
Journal: Anticancer Res. 1996 Jul-Aug;16(4B):2129-33.
Title: Novel approaches to tumor detection and therapy using a combination of monoclonal antibody and cytokine.
Author: Greiner, J W|Guadagni, F|Roselli, M|Nieroda, C A
PMID: 8694532
Journal: Anticancer Drugs. 1996 Jan;7(1):35-42.
Title: Combining 5-fluorouracil with interferon-alpha in the treatment of advanced colorectal cancer: optimism followed by disappointment.
Author: Kjaer, M
PMID: 8742096
Journal: Cancer Chemother Pharmacol. 1996;38(6):529-35.
Title: Effect of interferon on 5-fluorouracil-induced perturbations in pools of deoxynucleotide triphosphates and DNA strand breaks.
Author: Wadler, S|Horowitz, R|Mao, X|Schwartz, E L
PMID: 8823494
Journal: Br J Cancer. 1996 Sep;74(6):971-4.
Title: A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer.
Author: Piga, A|Cascinu, S|Latini, L|Marcellini, M|Bavosi, M|Acito, L|Bascioni, R|Giustini, L|Francini, G|Pancotti, A|Rossi, G|Del Papa, M|Carle, F|Cellerino, R
PMID: 8826868
Journal: Anticancer Drugs. 1996 Jul;7(5):520-4.
Title: A phase I trial of 5-fluorouracil, leucovorin and interferon-alpha 2b administered by 24 h infusion in metastatic colorectal carcinoma.
Author: Cascinu, S|Del Ferro, E|Ligi, M|Catalano, G
PMID: 8862717
Journal: Ann Oncol. 1996 Aug;7(6):575-9.
Title: 5-Fluorouracil versus 5-fluorouracil plus alpha-interferon as treatment of metastatic colorectal carcinoma. A randomized study.
Author: Dufour, P|Husseini, F|Dreyfus, B|Cure, H|Martin, C|Prevost, G|Olivier, J P|Dumas, F|Duclos, B|Olivares, R|Leszler, A|Bergerat, J P|Audhuy, B|Thill, L|Oberling, F
PMID: 8879370
Journal: Am J Clin Oncol. 1996 Dec;19(6):546-51.
Title: Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292.
Author: Sparano, J A|Lipsitz, S|Wadler, S|Hansen, R|Bushunow, P W|Kirkwood, J|Flynn, P J|Dutcher, J P|Benson, A B
PMID: 8931668
Journal: Br J Cancer. 1996 Dec;74(12):2018-23.
Title: Interleukin 2 and interferon alpha-2a do not improve anti-tumour activity of 5-fluorouracil in advanced colorectal cancer.
Author: Goey, S H|Gratama, J W|Primrose, J N|Ward, U|Mertelsmann, R H|Osterwalder, B|Verweij, J|Stoter, G
PMID: 8980407
Journal: Br J Cancer. 1997;75(3):423-6.
Title: A phase II study of recombinant interferon-beta (r-hIFN-beta 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma.
Author: Joffe, J K|Perren, T J|Bradley, C|Primrose, J|Hallam, S|Ward, U|Illingworth, J M|Selby, P J
PMID: 9020490
Journal: Cancer. 1997 Mar 15;79(6):1094-9.
Title: Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
Author: Tournigand, C|Louvet, C|de Gramont, A|Lucchi, E|Seitz, J F|Mal, F|Raymond, E|Cady, J|Carola, E|Krulik, M
PMID: 9070485
Journal: Jpn J Cancer Res. 1997 Feb;88(2):198-204.
Title: Histocompatibility leukocyte antigen-A2402-restricted cytotoxic T lymphocytes recognizing adenocarcinoma in tumor-infiltrating lymphocytes of patients with colon cancer.
Author: Gohara, R|Nakao, M|Ogata, Y|Isomoto, H|Oizumi, K|Itoh, K
PMID: 9119749
Journal: Eur J Cancer. 1997 Mar;33(3):471-8.
Title: Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cells.
Author: van der Wilt, C L|Smid, K|Aherne, G W|Noordhuis, P|Peters, G J
PMID: 9155534
Journal: Cancer J Sci Am. 1997 Sep-Oct;3(5):284-8.
Title: Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292)
Author: Wadler, S|Bajaj, R|Neuberg, D|Agarwal, V|Haynes, H|Benson, A B 3rd
PMID: 9327152
Journal: J Interferon Cytokine Res. 1997 Nov;17(11):681-93.
Title: Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro.
Author: Lindner, D J|Borden, E C
PMID: 9402106
Journal: Clin Cancer Res. 1997 Aug;3(8):1317-22.
Title: Combination therapy with 5-fluorouracil and IFN-alpha2a induces a nonrandom increase in DNA fragments of less than 3 megabases in HT29 colon carcinoma cells.
Author: Horowitz, R W|Heerdt, B G|Hu, X|Schwartz, E L|Wadler, S
PMID: 9815814
Journal: Br J Cancer. 1998;77(2):341-6.
Title: Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II study.
Author: Aschele, C|Guglielmi, A|Frassineti, G L|Milandri, C|Amadori, D|Labianca, R|Vinci, M|Tixi, L|Caroti, C|Ciferri, E|Verdi, E|Rosso, R|Sobrero, A
PMID: 9461008
Journal: Mol Pharmacol. 1998 Feb;53(2):252-61.
Title: Modulation of fluorouracil cytotoxicity by interferon-alpha and -gamma.
Author: Ismail, A|Van Groeningen, C J|Hardcastle, A|Ren, Q|Aherne, G W|Geoffroy, F|Allegra, C J|Grem, J L
PMID: 9463483
Journal: J Clin Oncol. 1998 Feb;16(2):418-26.
Title: Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer.
Author: Kohne, C H|Schoffski, P|Wilke, H|Kaufer, C|Andreesen, R|Ohl, U|Klaasen, U|Westerhausen, M|Hiddemann, W|Schott, G|Harstick, A|Bade, J|Horster, A|Schubert, U|Hecker, H|Dorken, B|Schmoll, H J
PMID: 9469324
Journal: Cancer Res. 1998 Apr 1;58(7):1551-7.
Title: Regulation of expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in human colon carcinoma cells.
Author: Schwartz, E L|Wan, E|Wang, F S|Baptiste, N
PMID: 9537263
Journal: Br J Cancer. 1998 Oct;78(8):1018-23.
Title: Selective suppression of cytokine secretion in whole blood cell cultures of patients with colorectal cancer.
Author: Lahm, H|Schindel, M|Frikart, L|Cerottini, J P|Yilmaz, A|Givel, J C|Fischer, J R
PMID: 9792144
Journal: Clin Cancer Res. 1998 Oct;4(10):2337-47.
Title: Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
Author: Bukowski, R M|Rayman, P|Uzzo, R|Bloom, T|Sandstrom, K|Peereboom, D|Olencki, T|Budd, G T|McLain, D|Elson, P|Novick, A|Finke, J H
PMID: 9796963
Journal: Anticancer Drugs. 1998 Sep;9(8):689-96.
Title: Pharmacokinetics of recombinant human interferon-alpha 2a combined with 5-fluorouracil in patients with advanced colorectal carcinoma.
Author: Kim, J|Zhi, J|Satoh, H|Koss-Twardy, S G|Passe, S M|Patel, I H|Pazdur, R
PMID: 9823427
Journal: J Natl Cancer Inst. 1998 Dec 2;90(23):1810-6.
Title: Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.
Author: Wolmark, N|Bryant, J|Smith, R|Grem, J|Allegra, C|Hyams, D|Atkins, J|Dimitrov, N|Oishi, R|Prager, D|Fehrenbacher, L|Romond, E|Colangelo, L|Fisher, B
PMID: 9839521
Journal: Cancer. 1999 Jan 15;85(2):290-4.
Title: A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
Author: Hudes, G R|Lipsitz, S|Grem, J|Morrisey, M|Weiner, L|Kugler, J W|Benson, A 3rd
PMID: 10023694
Journal: Cancer. 1999 Feb 1;85(3):535-45.
Title: 5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group.
Author: Colucci, G|Maiello, E|Gebbia, V|Giuliani, F|Serravezza, G|Lelli, G|Leo, S|Filippelli, G|Nicolella, G|Brandi, M
PMID: 10091727
Journal: Acta Haematol. 1999;101(2):82-8.
Title: Synergetic effects of retrovirus IFN-alpha gene transfer and 5-FU on apoptosis of colon cancer cells.
Author: Sabaawy, H E|Farley, T|Ahmed, T|Feldman, E|Abraham, N G
PMID: 10202238
Journal: Hybridoma. 1999 Feb;18(1):63-8.
Title: Enhancement of antibody dependent cellular cytotoxicity (ADCC) by combination of cytokines.
Author: Flieger, D|Spengler, U|Beier, I|Kleinschmidt, R|Hoff, A|Varvenne, M|Sauerbruch, T|Schmidt-Wolf, I
PMID: 10211790
Journal: Eur J Surg Oncol. 1999 Apr;25(2):179-85.
Title: Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan.
Author: Lindner, P|Fjalling, M|Hafstrom, L|Kierulff-Nielsen, H|Mattsson, J|Schersten, T|Rizell, M|Naredi, P
PMID: 10218462
Journal: Int J Oncol. 1999 Jun;14(6):1143-51.
Title: Enhancement of 5-fluorouracil cytotoxicity on human colon cancer cells by retrovirus-mediated interferon-alpha gene transfer.
Author: Sabaawy, H M|Ikehara, S|Adachi, Y|Quan, S|Feldman, E|Kancherla, R|Abraham, N G|Ahmed, T
PMID: 10339671
Journal: Eur J Cancer. 1999 Mar;35(3):380-5.
Title: Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon-alpha-2c in patients with advanced colorectal cancer: final results of a randomised phase III study.
Author: Hausmaninger, H|Moser, R|Samonigg, H|Mlineritsch, B|Schmidt, H|Pecherstorfer, M|Fridrik, M|Kopf, C|Nitsche, D|Kaider, A|Ludwig, H
PMID: 10448286
Journal: Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14007-12.
Title: Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells.
Author: Karpf, A R|Peterson, P W|Rawlins, J T|Dalley, B K|Yang, Q|Albertsen, H|Jones, D A
PMID: 10570189
Journal: Semin Oncol. 1999 Dec;26(6):663-71.
Title: Interferons as biomodulators of fluoropyrimidines in the treatment of colorectal cancer.
Author: Makower, D|Wadler, S
PMID: 10606259
Journal: Colorectal Dis. 1999 Sep;1(5):286-91.
Title: Influence of peri-operative immunotherapy on serum cytokines and soluble cytokine receptors in patients undergoing surgery for colorectal cancer.
Author: Nichols|Ward|Gallati|Primrose
PMID: 23577850
Journal: Cancer Res. 2000 Apr 1;60(7):2007-17.
Title: Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways.
Author: Remacle-Bonnet, M M|Garrouste, F L|Heller, S|Andre, F|Marvaldi, J L|Pommier, G J
PMID: 10766192
Journal: Cancer Res. 2000 Jun 15;60(12):3200-6.
Title: Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate.
Author: Huang, Y|Horvath, C M|Waxman, S
PMID: 10866311
Journal: Dermatology. 2000;200(4):331-3.
Title: Muir-Torre syndrome - treatment with isotretinoin and interferon alpha-2a can prevent tumour development.
Author: Graefe, T|Wollina, U|Schulz, H|Burgdorf, W
PMID: 10894967
Journal: Clin Cancer Res. 2000 Jul;6(7):2881-90.
Title: Augmentation of antitumor activity of 5-fluorouracil by interferon alpha is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells.
Author: Eguchi, H|Nagano, H|Yamamoto, H|Miyamoto, A|Kondo, M|Dono, K|Nakamori, S|Umeshita, K|Sakon, M|Monden, M
PMID: 10914738
Journal: J Immunother. 2000 Jul-Aug;23(4):480-6.
Title: Augmentation of 17-1A-induced antibody-dependent cellular cytotoxicity by the triple cytokine combination of interferon-alpha, interleukin-2, and interleukin-12.
Author: Flieger, D|Spengler, U|Beier, I|Kleinschmidt, R|Sauerbruch, T|Schmidt-Wolf, I G
PMID: 10916758
Journal: Z Gastroenterol. 2000 Aug;38(8):615-22.
Title: Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A.
Author: Flieger, D|Spengler, U|Beier, I|Sauerbruch, T|Schmidt-Wolf, I G
PMID: 11031784
Journal: Clin Exp Immunol. 2001 Jan;123(1):9-14.
Title: Influence of cytokines, monoclonal antibodies and chemotherapeutic drugs on epithelial cell adhesion molecule (EpCAM) and LewisY antigen expression.
Author: Flieger, D|Hoff, A S|Sauerbruch, T|Schmidt-Wolf, I G
PMID: 11167991
Journal: Tissue Antigens. 2001 Jan;57(1):39-45.
Title: Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokines.
Author: Seliger, B|Schreiber, K|Delp, K|Meissner, M|Hammers, S|Reichert, T|Pawlischko, K|Tampe, R|Huber, C
PMID: 11169257
Journal: Cell Death Differ. 2002 Jul;9(7):768-79.
Title: Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism.
Author: Garrouste, F|Remacle-Bonnet, M|Fauriat, C|Marvaldi, J|Luis, J|Pommier, G
PMID: 12058282
Journal: Semin Oncol. 2002 Jun;29(3 Suppl 7):18-26.
Title: Cancer immunotherapy: the interferon-alpha experience.
Author: Kirkwood, John
PMID: 12068384
Journal: Cancer Immunol Immunother. 2002 Jul;51(5):248-54.
Title: Interferon-alpha (Intron A) upregulates urokinase-type plasminogen activator receptor gene expression.
Author: Wu, Shanshan|Murrell, George A C|Wang, Yao
PMID: 12070711
Journal: Magy Onkol. 2002;46(4):297-300. Epub 2003 Feb 1.
Title: [Report on the first year of the activity of the National Oncological RD Consortium].
Author: Timar, Jozsef
PMID: 12563351
Journal: Cell Death Differ. 2003 Jun;10(6):718-28.
Title: TNF combined with IFN-alpha accelerates NF-kappaB-mediated apoptosis through enhancement of Fas expression in colon cancer cells.
Author: Kimura, M|Haisa, M|Uetsuka, H|Takaoka, M|Ohkawa, T|Kawashima, R|Yamatsuji, T|Gunduz, M|Kaneda, Y|Tanaka, N|Naomoto, Y
PMID: 12761580
Journal: Semin Oncol. 2003 Jun;30(3 Suppl 6):68-77.
Title: Optimal use of the combination of irinotecan and 5-fluorouracil.
Author: Benson, Al B 3rd|Goldberg, Richard M
PMID: 12802797
Journal: J Biol Chem. 2003 Nov 21;278(47):46278-87. Epub 2003 Sep 12.
Title: Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression.
Author: Klampfer, Lidija|Huang, Jie|Corner, Georgia|Mariadason, John|Arango, Diego|Sasazuki, Takehiko|Shirasawa, Senji|Augenlicht, Leonard
PMID: 12972432
Journal: Cancer. 2003 Dec 15;98(12):2730-3.
Title: Free interferon-alpha/beta receptors in the circulation of patients with adenocarcinoma.
Author: Ambrus, Julian L Sr|Dembinski, Wlodzimierz|Ambrus, Julian L Jr|Sykes, Donald E|Akhter, Selina|Kulaylat, Mahmoud N|Islam, Abul|Chadha, Kailash C
PMID: 14669296
Journal: Gut. 2004 Jan;53(1):123-9.
Title: Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon alpha.
Author: Yang, J-L|Qu, X-J|Russell, P J|Goldstein, D
PMID: 14684586
Journal: J Immunol. 2004 Apr 1;172(7):4630-6.
Title: Recruitment of STAT3 for production of IL-10 by colon carcinoma cells induced by macrophage-derived IL-6.
Author: Herbeuval, Jean-Philippe|Lelievre, Eric|Lambert, Claude|Dy, Michel|Genin, Christian
PMID: 15034082
Journal: Cell Cycle. 2004 Aug;3(8):1043-5. Epub 2004 Aug 8.
Title: Induction of p53-dependent apoptosis in HCT116 tumor cells by RNA viruses and possible implications in virus-mediated oncolysis.
Author: Huang, Shirley|Qu, Li-Ke|Koromilas, Antonis E
PMID: 15254403
Journal: J Clin Invest. 2004 Aug;114(3):370-8.
Title: Cancer cachexia is regulated by selective targeting of skeletal muscle gene products.
Author: Acharyya, Swarnali|Ladner, Katherine J|Nelsen, Lori L|Damrauer, Jeffrey|Reiser, Peter J|Swoap, Steven|Guttridge, Denis C
PMID: 15286803
Journal: Lab Invest. 2005 Jan;85(1):124-36.
Title: Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-catenin.
Author: Bataille, Frauke|Rogler, Gerhard|Modes, Katharina|Poser, Ina|Schuierer, Marion|Dietmaier, Wolfgang|Ruemmele, Petra|Muhlbauer, Marcus|Wallner, Susanne|Hellerbrand, Claus|Bosserhoff, Anja-Katrin
PMID: 15492751
Journal: Gene Ther. 2005 May;12(9):733-41.
Title: Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction.
Author: Eguchi, J|Hiroishi, K|Ishii, S|Baba, T|Matsumura, T|Hiraide, A|Okada, H|Imawari, M
PMID: 15772692
Journal: Ann Surg. 2005 Aug;242(2):178-87.
Title: Increase of survival benefit in advanced resectable colon cancer by extent of adjuvant treatment: results of a randomized trial comparing modulation of 5-FU + levamisole with folinic acid or with interferon-alpha.
Author: Link, Karl-Heinz|Kornmann, Marko|Staib, Ludger|Redenbacher, Martin|Kron, Martina|Beger, Hans Gunter
PMID: 16041207
Journal: Oncology. 2005;69(3):224-38. Epub 2005 Sep 1.
Title: Interferon-alpha promotes the anti-proliferative effect of gefitinib (ZD 1839) on human colon cancer cell lines.
Author: Yang, Jia-Lin|Qu, Xian-Jun|Russell, Pamela J|Goldstein, David
PMID: 16138001
Journal: Oncology. 2005;69 Suppl 3:34-45.
Title: The future development of bevacizumab in colorectal cancer.
Author: Diaz-Rubio, Eduardo|Schmoll, Hans-Joachim
PMID: 16301834
Journal: Am J Clin Oncol. 2005 Dec;28(6):565-9.
Title: Efficacy and tolerability of oxaliplatin plus irinotecan 5-fluouracil and leucovorin regimen in advanced stage colorectal cancer patients pretreated with irinotecan 5-fluouracil and leucovorin.
Author: Stathopoulos, George P|Rigatos, Sotiris K|Stathopoulos, John G|Xynotroulas, John P|Dimou, Evangelini
PMID: 16317265
Journal: Histol Histopathol. 2006 Jul;21(7):753-60.
Title: Perioperative IFN-alpha to avoid surgically induced immune suppression in colorectal cancer patients.
Author: Oosterling, S J|van der Bij, G J|Mels, A K|Beelen, R H J|Meijer, S|van Egmond, M|van Leeuwen, P A M
PMID: 16598674
Journal: Adv Med Sci. 2006;51:39-45.
Title: Overview how adenocarcinoma cancer cells avoid immune- and chemotherapy-induced apoptosis.
Author: Pajak, B|Orzechowski, A
PMID: 17357275
Journal: J Pharmacol Sci. 2007 Feb;103(2):155-8. Epub 2007 Feb 14.
Title: Circadian rhythms in the CNS and peripheral clock disorders: chronopharmacological findings on antitumor drugs.
Author: Ohdo, Shigehiro
PMID: 17299245
Journal: Ann N Y Acad Sci. 2007 Sep;1112:225-34. Epub 2007 Jun 28.
Title: Thymosin alpha 1: from bench to bedside.
Author: Garaci, Enrico|Favalli, Cartesio|Pica, Francesca|Sinibaldi Vallebona, Paola|Palamara, Anna Teresa|Matteucci, Claudia|Pierimarchi, Pasquale|Serafino, Annalucia|Mastino, Antonio|Bistoni, Francesco|Romani, Luigina|Rasi, Guido
PMID: 17600290
Journal: Int J Oncol. 2007 Sep;31(3):613-20.
Title: Type I interferon prolongs cell cycle progression via p21WAF1/CIP1 induction in human colon cancer cells.
Author: Katayama, Tomonari|Nakanishi, Kazuaki|Nishihara, Hiroshi|Kamiyama, Naoya|Nakagawa, Takahito|Kamiyama, Toshiya|Iseki, Ken|Tanaka, Shinya|Todo, Satoru
PMID: 17671689
Journal: Oncol Rep. 2007 Oct;18(4):1039-45.
Title: IFN-alpha competes with TNF-alpha for STAT-1alpha; molecular basis for immune escape of human colon adenocarcinoma COLO 205 cells.
Author: Pajak, Beata|Orzechowski, Arkadiusz
PMID: 17786371
Journal: J Chemother. 2007 Dec;19(6):739-43.
Title: Retrospective comparison of two different schedules of irinotecan, 5-fluorouracil and folinic acid in previously untreated patients with advanced colorectal carcinoma: a single institution experience.
Author: Gluzman, A|Rubinov, K|Mermershtain, W|Man, S|Ariad, S|Lavrenkov, K
PMID: 18230559
Journal: PLoS Med. 2008 May 20;5(5):e94.
Title: A novel tumor-promoting function residing in the 5' non-coding region of vascular endothelial growth factor mRNA.
Author: Masuda, Kiyoshi|Teshima-Kondo, Shigetada|Mukaijo, Mina|Yamagishi, Naoko|Nishikawa, Yoshiko|Nishida, Kensei|Kawai, Tomoko|Rokutan, Kazuhito
PMID: 18494554
Journal: Cancer Sci. 2010 Jul;101(7):1610-7.
Title: TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis.
Author: Taura, Manabu|Fukuda, Ryosuke|Suico, Mary Ann|Eguma, Ayaka|Koga, Tomoaki|Shuto, Tsuyoshi|Sato, Takashi|Morino-Koga, Saori|Kai, Hirofumi
PMID: 20367642
Journal: Gan To Kagaku Ryoho. 2010 Nov;37(12):2608-10.
Title: [A long-term disease-free survival case of advanced rectal cancer with massive metastasis to the lateral pelvic and para-aortic lymph nodes].
Author: Shingai, Tatsushi|Ohue, Masayuki|Noura, Shingo|Kano, Shingo|Gotoh, Kunihito|Motoori, Masaaki|Takahashi, Hidenori|Kishi, Kentaro|Yamada, Terumasa|Miyashiro, Isao|Ohigashi, Hiroaki|Yano, Masahiko|Ishikawa, Osamu
PMID: 21224654
Journal: Cancer Sci. 2011 Jun;102(6):1181-7.
Title: Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients.
Author: Kameshima, Hidekazu|Tsuruma, Tetsuhiro|Torigoe, Toshihiko|Takahashi, Akari|Hirohashi, Yoshihiko|Tamura, Yasuaki|Tsukahara, Tomohide|Ichimiya, Shingo|Kanaseki, Takayuki|Iwayama, Yuji|Sato, Noriyuki|Hirata, Koichi
PMID: 21371173
Journal: West Indian Med J. 2011 Mar;60(2):107-13.
Title: The effect of combining interferon-alpha and gefitinib in human colon cancer cell lines.
Author: Yang, Li|Wang, Fang|He, Fang|Huang, LiYa
PMID: 21942111
Journal: Oncotarget. 2011 Dec;2(12):1155-64.
Title: Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects.
Author: Yi, Taolin|Elson, Paul|Mitsuhashi, Masato|Jacobs, Barbara|Hollovary, Emese|Budd, Thomas G|Spiro, Timothy|Triozzi, Pierre|Borden, Ernest C
PMID: 22201704
Journal: Invest New Drugs. 2012 Feb;30(1):395-402.
Title: Combined treatment with bevacizumab and standard chemotherapy restores abnormal immune parameters in advanced colorectal cancer patients.
Author: Tsavaris, Nikolaos|Voutsas, Ioannis F|Kosmas, Christos|Gritzapis, Angelos D|Baxevanis, Constantin N
PMID: 20820907
Journal: Gene Ther. 2012 Mar;19(3):271-8.
Title: A Semliki forest virus vector engineered to express IFNalpha induces efficient elimination of established tumors.
Author: Quetglas, J I|Fioravanti, J|Ardaiz, N|Medina-Echeverz, J|Baraibar, I|Prieto, J|Smerdou, C|Berraondo, P
PMID: 21734727
Journal: Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Jul;15(7):719-22.
Title: [Influence of interferon-alpha2a on thymidine phosphorylase expression and anticancer activity of 5'-deoxy-fluorouridine in human colon carcinoma cell lines LOVO and SW480].
Author: Xia, Qiang|Wang, Qi-wen|Zhang, Ji-min
PMID: 22851078
Journal: Oncol Lett. 2012 Sep;4(3):546-550.
Title: (-)-Epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells.
Author: Ogawa, Kengo|Hara, Takeshi|Shimizu, Masahito|Nagano, Junji|Ohno, Tomohiko|Hoshi, Masato|Ito, Hiroyasu|Tsurumi, Hisashi|Saito, Kuniaki|Seishima, Mitsuru|Moriwaki, Hisataka
PMID: 23741252
Journal: Int J Cancer. 2013 Apr 1;132(7):1581-91.
Title: Addition of interferon-alpha to the p53-SLP(R) vaccine results in increased production of interferon-gamma in vaccinated colorectal cancer patients: a phase I/II clinical trial.
Author: Zeestraten, Eliane C M|Speetjens, Frank M|Welters, Marij J P|Saadatmand, Sepideh|Stynenbosch, Linda F M|Jongen, Rogier|Kapiteijn, Ellen|Gelderblom, Hans|Nijman, Hans W|Valentijn, A Rob P M|Oostendorp, Jaap|Fathers, Lorraine M|Drijfhout, Jan W|van de Velde
PMID: 22948952
Journal: Biochem Pharmacol. 2013 Feb 1;85(3):396-403.
Title: IFNalpha converts IL-22 into a cytokine efficiently activating STAT1 and its downstream targets.
Author: Bachmann, Malte|Ulziibat, Solongo|Hardle, Lorena|Pfeilschifter, Josef|Muhl, Heiko
PMID: 23153456
Journal: Oncol Rep. 2013 Dec;30(6):2845-51.
Title: Protein-bound polysaccharide-K augments the anticancer effect of fluoropyrimidine derivatives possibly by lowering dihydropyrimidine dehydrogenase expression in gastrointestinal cancers.
Author: Mekata, Eiji|Murata, Satoshi|Sonoda, Hiromichi|Shimizu, Tomoharu|Umeda, Tomoko|Shiomi, Hisanori|Naka, Shigeyuki|Yamamoto, Hiroshi|Abe, Hajime|Edamatsu, Takeo|Fujieda, Ayako|Fujioka, Masaki|Wada, Tsutomu|Tani, Tohru
PMID: 24100378
Journal: Clin Dev Immunol. 2013;2013:262967.
Title: Potential survival benefit of anti-apoptosis protein: survivin-derived peptide vaccine with and without interferon alpha therapy for patients with advanced or recurrent urothelial cancer--results from phase I clinical trials.
Author: Tanaka, Toshiaki|Kitamura, Hiroshi|Inoue, Ryuta|Nishida, Sachiyo|Takahashi-Takaya, Akari|Kawami, Sachiyo|Torigoe, Toshihiko|Hirohashi, Yoshihiko|Tsukamoto, Taiji|Sato, Noriyuki|Masumori, Naoya
PMID: 24363758
Journal: Zhonghua Zhong Liu Za Zhi. 2014 Mar;36(3):177-82.
Title: [Anti-tumor effect of Sendai virus Tianjin strain defective interfering particles on tumor-bearing mice].
Author: Shi, Liying|Chen, Jun|Zhong, Qiping|Geng, Peng|He, Jianmin
PMID: 24785276
Journal: Bioorg Med Chem. 2014 Jun 1;22(11):2912-8.
Title: Anti-inflammatory drimane sesquiterpene lactones from an Aspergillus species.
Author: Felix, Silke|Sandjo, Louis P|Opatz, Till|Erkel, Gerhard
PMID: 24792812
Journal: J Pathol. 2014 Nov;234(3):386-97.
Title: Up-regulation of the interferon-related genes in BRCA2 knockout epithelial cells.
Author: Xu, Hong|Xian, Jian|Vire, Emmanuelle|McKinney, Steven|Wei, Vivien|Wong, Jason|Tong, Rebecca|Kouzarides, Tony|Caldas, Carlos|Aparicio, Samuel
PMID: 25043256
Journal: PLoS One. 2014 Oct 28;9(10):e111061.
Title: Single nucleotide polymorphisms within interferon signaling pathway genes are associated with colorectal cancer susceptibility and survival.
Author: Lu, Shun|Pardini, Barbara|Cheng, Bowang|Naccarati, Alessio|Huhn, Stefanie|Vymetalkova, Veronika|Vodickova, Ludmila|Buchler, Thomas|Hemminki, Kari|Vodicka, Pavel|Forsti, Asta
PMID: 25350395
Journal: DNA Cell Biol. 2015 Aug;34(8):541-9.
Title: The Tumor Suppressive Effects of HPP1 Are Mediated Through JAK-STAT-Interferon Signaling Pathways.
Author: Hernandez, Jonathan M|Elahi, Abul|Clark, Whalen|Humphries, Leigh Ann|Wang, Jian|Achille, Alex|Seto, Ed|Shibata, David
PMID: 26061044
Journal: Oncotarget. 2016 Apr 19;7(16):22174-85.
Title: Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer.
Author: Francis, Lily|Guo, Zong Sheng|Liu, Zuqiang|Ravindranathan, Roshni|Urban, Julie A|Sathaiah, Magesh|Magge, Deepa|Kalinski, Pawel|Bartlett, David L
PMID: 26956047
Journal: Biomed Pharmacother. 2016 Oct;83:1247-1252.
Title: Xenogeneic cell-based vaccine therapy for colorectal cancer: Safety, association of clinical effects with vaccine-induced immune responses.
Author: Seledtsova, G V|Shishkov, A A|Kaschenko, E A|Seledtsov, V I
PMID: 27565847
Journal: Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):E7240-E7249.
Title: Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells.
Author: Wang, Shu|Campos, Jose|Gallotta, Marilena|Gong, Mei|Crain, Chad|Naik, Edwina|Coffman, Robert L|Guiducci, Cristiana
PMID: 27799536
Journal: Eur J Pharmacol. 2017 Jun 5;804:46-51.
Title: Astilbin from Engelhardtia chrysolepis enhances intestinal barrier functions in Caco-2 cell monolayers.
Author: Nakahara, Tatsuo|Nishitani, Yosuke|Nishiumi, Shin|Yoshida, Masaru|Azuma, Takeshi
PMID: 28327343
Journal: J Immunother Cancer. 2017 Mar 21;5:22.
Title: Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer.
Author: Hege, Kristen M|Bergsland, Emily K|Fisher, George A|Nemunaitis, John J|Warren, Robert S|McArthur, James G|Lin, Andy A|Schlom, Jeffrey|June, Carl H|Sherwin, Stephen A
PMID: 28344808
Journal: Biochem Biophys Res Commun. 2017 Sep 9;491(1):159-165.
Title: Inhibition of IL-6/STAT3 signaling in human cancer cells using Evista.
Author: Shi, Wei|Yan, Dan|Zhao, Chongqiang|Xiao, Miaomiao|Wang, Yina|Ma, Haiyan|Liu, Tianshu|Qin, Hua|Zhang, Cuntai|Li, Chenglong|Lin, Jiayuh|Li, Sheng|Lv, Jiagao|Lin, Li
PMID: 28711499
Journal: Cancer Immunol Res. 2017 Nov;5(11):942-949.
Title: A Blueprint to Advance Colorectal Cancer Immunotherapies.
Author: Le, Dung T|Hubbard-Lucey, Vanessa M|Morse, Michael A|Heery, Christopher R|Dwyer, Andrea|Marsilje, Thomas H|Brodsky, Arthur N|Chan, Emily|Deming, Dustin A|Diaz, Luis A Jr|Fridman, Wolf H|Goldberg, Richard M|Hamilton, Stanley R|Housseau, Franck|Jaffee, Eliz
PMID: 29038296
Journal: Front Immunol. 2018 Jul 10;9:1578.
Title: Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location.
Author: Zhang, Longhui|Zhao, Yuetao|Dai, Ying|Cheng, Jia-Nan|Gong, Zhihua|Feng, Yi|Sun, Chengdu|Jia, Qingzhu|Zhu, Bo
PMID: 30042763
Journal: J Cachexia Sarcopenia Muscle. 2018 Oct 3.
Title: Peritumoural adipose tissue pro-inflammatory cytokines are associated with tumoural growth factors in cancer cachexia patients.
Author: Neto, Nelson Inacio Pinto|Murari, Ariene Soares de Pinho|Oyama, Lila Missae|Otoch, Jose Pinhata|Alcantara, Paulo Sergio Martins|Tokeshi, Flavio|Figueredo, Raquel Galvao|Alves, Michele Joana|Lima, Joanna Darck Carola Correia|Matos-Neto, Emidio Marques de|S
PMID: 30284380
Journal: J Cell Physiol. 2018 Nov 1.
Title: Toll-like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3-UNC93B1-IFN-beta signaling axis in paclitaxel-resistant colon cancer.
Author: Zhao, Jiaojiao|Xue, Yaxian|Pan, Yuchen|Yao, Anran|Wang, Guoqun|Li, Dan|Wang, Tingting|Zhao, Shuli|Hou, Yayi
PMID: 30387134